Sara Cuadrado-Castano
7PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 05, 2025
Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma.Vicent Tur-Planells, Yonina Bykov, Gloria Dawodu
|Sep 15, 2025
Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy.Ruben Fernandez-Rodriguez, Sara Cuadrado-Castano, Andrew Edwards
|Nov 23, 2024
Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice.Gagandeep Singh, Juan García-Bernalt Diego, Prajakta Warang
|Dec 11, 2023
Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.Gagandeep Singh, Prajakta Warang, Juan García-Bernalt Diego
|Oct 28, 2023
Engineering Non-Human RNA Viruses for Cancer Therapy.Vicent Tur-Planells, Adolfo García-Sastre, Sara Cuadrado-Castano
|Nov 23, 2022
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.Judit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia
Pageof 2
Frequent Collaborators
6 joint publications
Adolfo García-Sastre
2 joint publications
Lars Pache
2 joint publications
Lauren Chang
2 joint publications
Michael Schotsaert
2 joint publications
Gagandeep Singh
2 joint publications
Estanislao Nistal-Villan
1 joint publications
Jose-Ignacio Rodriguez-Barbosa
1 joint publications
Rodrigo Madurga
1 joint publications
Angel Ayuso-Sacido
1 joint publications
Judit Svensson-Arvelund
